Today: 1 May 2026
Costco pulls ‘no preservatives’ rotisserie chicken signs after additives lawsuit
3 February 2026
2 mins read

Costco pulls ‘no preservatives’ rotisserie chicken signs after additives lawsuit

San Diego, Feb 3, 2026, 08:40 (PST)

  • Costco confirmed it has taken down “no preservatives” claims from signs and online listings for its rotisserie chicken
  • Two consumers from California claim the chicken includes sodium phosphate and carrageenan, which they say serve as preservatives
  • The lawsuit aims to secure class-action status for buyers across the U.S., with a specific subclass designated for those in California

Costco Wholesale Corp. has taken down “no preservatives” labels from signs and online listings for its Kirkland rotisserie chicken following a proposed class action by two California consumers alleging the claim was deceptive. The company told MEAT+POULTRY it “removed statements concerning preservatives” to maintain consistent labeling. It added that ingredients like carrageenan and sodium phosphate, which aid moisture retention and texture, are approved by food safety regulators. Wesley M. Griffith, the plaintiffs’ attorney, said Costco’s quick removal of the wording confirms the “no preservative” claims were inaccurate. meatpoultry.com

The clash centers on a popular prepared-food item, hitting retailers and food producers as regulators zero in on straightforward ingredient claims that influence buyers right at checkout. Costco shares gained roughly 1.6% in Tuesday’s morning session.

The complaint, filed Jan. 22 in the U.S. District Court for the Southern District of California, aims to represent a nationwide class of U.S. buyers along with a California-specific subclass, according to court documents. It identifies plaintiffs Bianca Johnston and Anatasia Chernov, who say they purchased the rotisserie chicken after encountering “no preservatives” claims both in-store and online, including at a Victorville, California location in December 2024 and a San Marcos, California store in February 2025.

Sodium phosphate and carrageenan frequently appear as food additives; the lawsuit claims they act as preservatives, but Costco insists they’re there to improve moisture and texture. The rotisserie chicken goes for less than $5, and some retail analysts label it a “loss leader” — priced low or even at a loss to lure customers inside. Los Angeles Times

U.S. food-labeling regulations define a “chemical preservative” as any chemical added to food that “tends to prevent or retard deterioration.” This definition often sparks debates over whether an ingredient qualifies as a preservative or simply serves as a texture or processing aid. ecfr.gov

A class action lawsuit represents a larger group of people with similar claims, potentially increasing the financial risks if a judge allows it to move forward. The plaintiffs highlight “clean label” marketing — an industry buzzword for foods marketed as free from certain additives — as a key selling point Costco relied on.

Warehouse retailers like Sam’s Club and BJ’s Wholesale Club battle fiercely over ready-to-eat food and private-label trust. Here, quick claims on signs often carry as much weight as the detailed print on packaging.

But proposed consumer class actions frequently hit roadblocks right away. Costco may move to dismiss the suit or limit its scope, leaving the judge to determine if shoppers would realistically interpret “no preservatives” as the plaintiffs allege.

Removing a sign doesn’t necessarily close the case. Plaintiffs may still pursue damages for previous purchases if they convince the court the marketing was misleading. Costco hasn’t indicated any intention to alter the product’s ingredients.

Stock Market Today

  • SoftBank-Backed OPay Targets $4 Billion Valuation in U.S. IPO
    May 1, 2026, 2:17 PM EDT. SoftBank-backed digital banking platform OPay plans a U.S. initial public offering (IPO) aiming for a $4 billion valuation, doubling its 2021 valuation of $2 billion. Founded by Chinese entrepreneur James Yahui Zhou, OPay serves 40 million users and raised $400 million in a 2021 funding round, marking SoftBank's first investment in Africa. The company announced a new global core management team including Zhou as executive chairman and former Citigroup director James Perry as CFO, expected to drive its global expansion. OPay recently opened an office in Nigeria to boost financial service access. The IPO could launch by year-end, positioning OPay as a key player in emerging markets digital banking.

Latest article

Eaton Stock Just Hit a New High. The May 5 Earnings Test Is Bigger Than Usual

Eaton Stock Just Hit a New High. The May 5 Earnings Test Is Bigger Than Usual

1 May 2026
Eaton shares fell 1.5% to $426.44 Friday after hitting a record $437.98, as investors awaited first-quarter earnings due May 5. The stock had surged 5.4% on April 30 amid optimism over AI data-center demand. Eaton forecast Q1 organic growth of 5% to 7% and margins up to 22.6%. Peers like Schneider Electric also reported strong results tied to data-center spending.
Wolfspeed Stock Jumps as 5% Stake and New Executives Put Turnaround in Focus

Wolfspeed Stock Jumps as 5% Stake and New Executives Put Turnaround in Focus

1 May 2026
Wolfspeed shares rose $7.61 to $37.14 after a group linked to Susquehanna and Capital Ventures disclosed a 5% stake in the chipmaker, according to an SEC filing. The disclosure comes days before Wolfspeed’s May 5 earnings call and follows its March debt refinancing. More than 5.3 million shares traded Friday. Wolfspeed exited Chapter 11 bankruptcy last September.
Esperion Stock Surges On ARCHIMED’s $1.1 Billion Buyout — What Shareholders Get Next

Esperion Stock Surges On ARCHIMED’s $1.1 Billion Buyout — What Shareholders Get Next

1 May 2026
ARCHIMED will acquire Esperion Therapeutics for $3.16 per share in cash plus a contingent value right tied to future sales, valuing the deal at up to $1.1 billion. Esperion shares surged 56% to near the cash offer after the announcement. The CVR could pay up to $100 million if sales targets are met. The deal follows Esperion’s recent expansion beyond cholesterol drugs.
Tesla stock today: TSLA edges higher after $41,990 Model Y AWD launch as Europe sales signals split
Previous Story

Tesla stock today: TSLA edges higher after $41,990 Model Y AWD launch as Europe sales signals split

Netflix stock slides as Senate antitrust hearing revives Warner Bros deal jitters
Next Story

Netflix stock slides as Senate antitrust hearing revives Warner Bros deal jitters

Go toTop